Syros Pharmaceuticals (SYRS) Stock Price, Quote & News

Latest News on SYRS

Nov 13, 2024, 12:11 PM EST - 2 months ago

Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default

Nov 12, 2024, 4:30 PM EST - 2 months ago

Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression

$The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions$

Nov 4, 2024, 11:00 AM EST - 2 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions

Nov 3, 2024, 11:00 AM EST - 2 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Oct 31, 2024, 2:21 PM EDT - 2 months ago

Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 11:00 AM EDT - 2 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 31, 2024, 7:30 AM EDT - 2 months ago

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update

Oct 30, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Oct 29, 2024, 11:00 AM EDT - 2 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 24, 2024, 7:08 AM EDT - 3 months ago

Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Oct 21, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 19, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 15, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 13, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Reach Out To The Schall Law Firm

Oct 9, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Oct 3, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Oct 2, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Oct 1, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Investors Are Invited To Contact The Schall Law Firm

Sep 29, 2024, 11:00 AM EDT - 3 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Investors Are Invited To Assist The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Sep 27, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Investors Are Urged To Assist The Schall Law Firm

Sep 26, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Violating Securities Laws

Sep 25, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Shareholders With Losses In Syros Pharmaceuticals, Inc. To Join An Inquiry For Securities Law Violations

Sep 23, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc Is Being Looked Into For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Sep 22, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Sep 21, 2024, 11:00 AM EDT - 4 months ago

Investors Are Urged To Join The Schall Law Firm In A Securities Fraud Inquiry Into Syros Pharmaceuticals Inc

Sep 20, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Wants Shareholders To Help With An Investigation

Sep 19, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Has Launched An Inquiry Into Syros Pharmaceuticals Inc's Possible Securities Fraud And Investors Are Urged To Join

Sep 18, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Encourages Affected Shareholders To Reach Out

Sep 17, 2024, 11:00 AM EDT - 4 months ago

Investors With Losses In Syros Pharmaceuticals Inc Can Join The Schall Law Firm's Securities Fraud Inquiry

$The Schall Law Firm Is Looking Into Syros Pharmaceuticals, Inc. For Possible Securities Related Infractions And Affected Shareholders Are Urged To Reach Out$

Sep 16, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Syros Pharmaceuticals, Inc. For Possible Securities Related Infractions And Affected Shareholders Are Urged To Reach Out

Sep 15, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc May Have Violated Securities Laws And The Schall Law Firm Wants Investors To Join An Inquiry

Sep 14, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders Are Urged To Reach Out

Sep 13, 2024, 11:00 AM EDT - 4 months ago

Investors Are Invited By The Schall Law Firm To Join An Inquiry Into Possible Securities Law Violations By Syros Pharmaceuticals Inc

Sep 12, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders With Losses Can Reach Out

Sep 11, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Securities Law Violations And The Firm Seeks Investor Participation

Sep 10, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals, Inc. Committed Securities Fraud And Shareholders Are Encouraged To Reach Out

Sep 9, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Assist The Schall Law Firm

Sep 8, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Shareholders to Connect

Sep 7, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Is Looking Into Whether Securities Fraud Was Committed By Syros Pharmaceuticals, Inc. And Shareholders Can Reach Out

Sep 6, 2024, 11:00 AM EDT - 4 months ago

Syros Pharmaceuticals Inc May Have Violated Securities Laws And Investors Are Invited To Join The Schall Law Firm In An Inquiry

Sep 6, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Stockholders to Connect

$The Schall Law Firm Seeks Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc.'s Potential Securities Related Infractions$

Sep 5, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Seeks Shareholder Participation In An Investigation Into Syros Pharmaceuticals, Inc.'s Potential Securities Related Infractions

Sep 5, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Investors to Connect

Sep 4, 2024, 4:00 PM EDT - 4 months ago

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Sep 4, 2024, 11:00 AM EDT - 4 months ago

An Inquiry Has Been Launched Into Syros Pharmaceuticals Inc.'s Potential Securities Law Violations And Stockholders Can Lend A Hand To The Schall Law Firm

Sep 4, 2024, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz and Grossman, LLC Initiates an Investigation into Allegations Against Syros Pharmaceuticals, Inc. (SYRS) And Encourages Stockholders to Reach Out

Market Cap	5.50M
Revenue (ttm)	9.94M
Net Income (ttm)	-164.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,655.63%
Debt to Equity Ratio	-3.69

Volume	1,180,500
Avg Vol	11,706,748
Day's Range	N/A - N/A
Shares Out	26.83M
Stochastic %K	52%
Beta	1.31
Analysts	Hold
Price Target	$1.00